APA

de Vries-Bouwstra J. K., Goekoop-Ruiterman Y. P. M., Verpoort K. N., Schreuder G. M. T., Ewals J. A. P. M., Terwiel J. P., Ronday H. K., Kerstens P. J. S. M., Toes R. E. M., de Vries R. R. P., Breedveld F. C., Dijkmans B. A. C., Huizinga T. W. J. & Allaart C. F. (20080623). Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies. : Arthritis and rheumatism.

Chicago

de Vries-Bouwstra J K, Goekoop-Ruiterman Y P M, Verpoort K N, Schreuder G M T, Ewals J A P M, Terwiel J P, Ronday H K, Kerstens P J S M, Toes R E M, de Vries R R P, Breedveld F C, Dijkmans B A C, Huizinga T W J and Allaart C F. 20080623. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies. : Arthritis and rheumatism.

Harvard

de Vries-Bouwstra J. K., Goekoop-Ruiterman Y. P. M., Verpoort K. N., Schreuder G. M. T., Ewals J. A. P. M., Terwiel J. P., Ronday H. K., Kerstens P. J. S. M., Toes R. E. M., de Vries R. R. P., Breedveld F. C., Dijkmans B. A. C., Huizinga T. W. J. and Allaart C. F. (20080623). Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies. : Arthritis and rheumatism.

MLA

de Vries-Bouwstra J K, Goekoop-Ruiterman Y P M, Verpoort K N, Schreuder G M T, Ewals J A P M, Terwiel J P, Ronday H K, Kerstens P J S M, Toes R E M, de Vries R R P, Breedveld F C, Dijkmans B A C, Huizinga T W J and Allaart C F. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies. : Arthritis and rheumatism. 20080623.